Erratum: Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro(DNA and Cell Biology (2009) 28:4 (161-167) doi: 10.1089/dna.2008.0778);Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro

DNA and Cell Biology

Volumn 28, Issue 4, 2009, Pages 161-167

  Trapasso, Francesco ^a,b   Aqeilan, Rami I ^a   Iuliano, Rodolfo ^b   Visone, Rosa ^c   Gaudio, Eugenio ^a,b   Ciuffini, Laura ^d   Alder, Hansjuerg ^a   Paduano, Francesco ^b   Pierantoni, Giovanna Maria ^c   Soddu, Silvia ^d   Croce, Carlo M ^a   Fusco, Alfredo ^c,e,f  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^f CEINGE Biotecnologie Avanzate   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE 6; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; CARRIER PROTEIN; HIPK2 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; BODY SIZE; CELL CYCLE; CYTOLOGY; FERTILITY; GENETICS; METABOLISM;

MURINAE; MUS;

ANIMALS; BODY SIZE; CARRIER PROTEINS; CELL CYCLE; CELL PROLIFERATION; FERTILITY; FIBROBLASTS; GENE TARGETING; MICE; PROTEIN-SERINE-THREONINE KINASES;

EID: 64549091827     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2008.0778.retract     Document Type: Erratum

References (26)

1. Bossi, G., Mazzaro, G., Porrello, A., Crescenzi, M., Soddu, S., and Sacchi, A. (2004). Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy. Oncogene 23, 418-425.
2. Calzado, M.A., Renner, F., Roscic, A., and Schmitz, M.L. (2007). HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 6, 139-143.
3. Choi, C.Y., Kim, Y.H., Kwon, H.J., and Kim, Y. (1999). The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J Biol Chem 274, 33194-33197.
4. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Saito, S., Gostissa, M., Coen, S., Marchetta, A., Del Sal, G., Piaggio, G., Fanciulli, M., Appella, E., and Soddu, S. (2002). Homeodomain-interacting protein kinase-2 phosphor-ylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4, 11-19.
5. Gresko, E., Roscic, A., Ritterhoff, S., Vichalkovski, A., del Sal, G., and Schmitz, M.L. (2006). Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J 25, 1883-1894.
6. Harada, J., Kokura, K., Kanei-Ishii, C., Nomura, T., Khan, M.M., Kim, Y., and Ishii, S. (2003). Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J Biol Chem 278, 38998-39005.
7. Hofmann, T.G., Mincheva, A., Lichter, P., Droge, W., and Schmitz, M.L. (2000). Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34. Biochimie 82, 1123-1127.
8. Hofmann, T.G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., and Schmitz, M.L. (2002). Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4, 1-10.
9. Iacovelli, S., Ciuffini, L., Lazzari, C., Bracaglia, G., Rinaldo, C., Prodosmo, A., Bartolazzi, A., Sacchi, A., and Soddu, S. (2009). HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Prolif (In press).
10. Isono, K., Nemoto, K., Li, Y., Takada, Y., Suzuki, R., Katsuki, M., Nakagawara, A., and Koseki, H. (2006). Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol Cell Biol 26, 2758-2771.
11. Kanei-Ishii, C., Nomura, T., Tanikawa, J., Ichikawa-Iwata, E., and Ishii, S. (2004). Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation. J Biol Chem 279, 44582-44589.
12. Kim, Y.H., Choi, C.Y., Lee, S.J., Conti, M.A., and Kim, Y. (1998). Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 273, 25875-25879.
13. Kim, E.J., Park, J.S., and Um, S.J. (2002). Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J Biol Chem 277, 32020-32028.
14. Li, Q., Wang, X., Wu, X., Rui, Y., Liu, W., Wang, J., Wang, X., Liou, Y.C., Ye, Z., and Lin, S.C. (2007). Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death. Cancer Res 67, 66-74.
15. Pierantoni, G.M., Fedele, M., Pentimalli, F., Benvenuto, G., Pero, R., Viglietto, G., Santoro, M., Chiariotti, L., and Fusco, A. (2001). High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 20, 6132-6141.
16. Pierantoni, G.M., Rinaldo, C., Esposito, F., Mottolese, M., Soddu, S., and Fusco, A. (2006). High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ 13, 1554-1563.
17. Pierantoni, G.M., Rinaldo, C., Mottolese, M., Di Benedetto, A., Esposito, F., Soddu, S., and Fusco, A. (2007). High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 117, 693-702.
18. Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., and Soddu, S. (2007). MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 25, 739-750.
19. Rinaldo, C., Siepi, F., Prodosmo, A., and Soddu, S. (2008). HIPKs: Jack of all traders in basic nuclear activities. Biochim Biophys Acta 1783, 2124-2129.
20. Roscic, A., Moller, A., Calzado, M.A., Renner, F., Wimmer, V.C., Gresko, E., Lüdi, K.S., and Schmitz, M.L. (2006). Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell 24, 77-89.
21. Rui, Y., Xu, Z., Lin, S., Li, Q., Rui, H., Luo, W., Zhou, H.M., Cheung, P.Y., Wu, Z., Ye, Z., Li, P., Han, J., and Lin, S.C. (2004). Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J 23, 4583-4594.
22. Wei, G., Ku, S., Ma, G.K., Saito, S., Tang, A.A., Zhang, J., Mao, J.H., Appella, E., Balmain, A., and Huang, E.J. (2007). HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci USA 104, 13040-13045.
23. Wiggins, A.K., Wei, G., Doxakis, E., Wong, C., Tang, A.A., Zang, K., Luo, E.J., Neve, R.L., Reichardt, L.F., and Huang, E.J. (2004). Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J Cell Biol 167, 257-267.
24. Yang, S., Delgado, R., King, S.R., Woffendin, C., Barker, C.S., Yang, Z.Y., Xu, L., Nolan, G.P., and Nabel, G.J. (1999). Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther 10, 123-132.
25. Zhang, Q., Yoshimatsu, Y., Hildebrand, J., Frisch, S.M., and Goodman, R.H. (2003). Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115, 177-186.
26. Zhang, J., Pho, V., Bonasera, S.J., Holtzman, J., Tang, A.T., Hellmuth, J., Tang, S., Janak, P.H., Tecott, L.H., and Huang, E.J. (2007). Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons. Nat Neurosci 10, 77-86.